Flexion Therapeutics: 2Q Earnings Snapshot
Posted August 5, 2020 2:59 pm.
Last Updated August 5, 2020 3:02 pm.
This article is more than 5 years old.
BURLINGTON, Mass. (AP) _ Flexion Therapeutics Inc. (FLXN) on Wednesday reported a loss of $32.6 million in its second quarter.
The Burlington, Massachusetts-based company said it had a loss of 76 cents per share.
The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 70 cents per share.
The specialty pharmaceutical companies that specializes in pain relief posted revenue of $15.5 million in the period, which met Street forecasts.
Flexion Therapeutics shares have declined 39% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $12.63, an increase of 38% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FLXN at https://www.zacks.com/ap/FLXN
The Associated Press